Cite as https://mymun.com/ppdb/3319
Topic A: Intellectual Property Rights and HIV/AIDS Medication
Argentina provides free, universal access to antiretroviral drugs, saving thousands of lives and an estimated US$748 million(1). It has achieved this through active negotiations with pharmaceutical companies and the threat of compulsory licensing(2). The government has also entered into international agreements to jointly produce generic drugs and share information, technology and expertise(3). These measures have enabled Argentina to continue providing both generic and non-generic drugs at as low a cost as possible.
For Argentina to continue providing these necessary drugs to its population, it is essential to bolster generic drug production globally. The TRIPS Agreement has slowed the entry of generic competition to far too great an extent, which has only been exacerbated by the proliferation of bilateral TRIPS Plus provisions(4). Both pharmaceutical companies and international law must recog...